Prediction of chronic thromboembolic pulmonary hypertension with standardised evaluation of initial computed tomography pulmonary angiography performed for suspected acute pulmonary embolism
- PMID: 34854928
- PMCID: PMC8921171
- DOI: 10.1007/s00330-021-08364-0
Prediction of chronic thromboembolic pulmonary hypertension with standardised evaluation of initial computed tomography pulmonary angiography performed for suspected acute pulmonary embolism
Abstract
Objectives: Closer reading of computed tomography pulmonary angiography (CTPA) scans of patients presenting with acute pulmonary embolism (PE) may identify those at high risk of developing chronic thromboembolic pulmonary hypertension (CTEPH). We aimed to validate the predictive value of six radiological predictors that were previously proposed.
Methods: Three hundred forty-one patients with acute PE were prospectively followed for development of CTEPH in six European hospitals. Index CTPAs were analysed post hoc by expert chest radiologists blinded to the final diagnosis. The accuracy of the predictors using a predefined threshold for 'high risk' (≥ 3 predictors) and the expert overall judgment on the presence of CTEPH were assessed.
Results: CTEPH was confirmed in nine patients (2.6%) during 2-year follow-up. Any sign of chronic thrombi was already present in 74/341 patients (22%) on the index CTPA, which was associated with CTEPH (OR 7.8, 95%CI 1.9-32); 37 patients (11%) had ≥ 3 of 6 radiological predictors, of whom 4 (11%) were diagnosed with CTEPH (sensitivity 44%, 95%CI 14-79; specificity 90%, 95%CI 86-93). Expert judgment raised suspicion of CTEPH in 27 patients, which was confirmed in 8 (30%; sensitivity 89%, 95%CI 52-100; specificity 94%, 95%CI 91-97).
Conclusions: The presence of ≥ 3 of 6 predefined radiological predictors was highly specific for a future CTEPH diagnosis, comparable to overall expert judgment, while the latter was associated with higher sensitivity. Dedicated CTPA reading for signs of CTEPH may therefore help in early detection of CTEPH after PE, although in our cohort this strategy would not have detected all cases.
Key points: • Three expert chest radiologists re-assessed CTPA scans performed at the moment of acute pulmonary embolism diagnosis and observed a high prevalence of chronic thrombi and signs of pulmonary hypertension. • On these index scans, the presence of ≥ 3 of 6 predefined radiological predictors was highly specific for a future diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH), comparable to overall expert judgment. • Dedicated CTPA reading for signs of CTEPH may help in early detection of CTEPH after acute pulmonary embolism.
Keywords: Chronis thromboembolic pulmonary hypertension; Computed tomography angiography; Pulmonary artery; Pulmonary embolism; Pulmonary hypertension.
© 2021. The Author(s).
Conflict of interest statement
GJAMB was supported by the Dutch Heart Foundation (2017T064).
YEV has no disclosures.
LFMB has no disclosures.
JC has no disclosures.
MD has no disclosures.
MG has no disclosures.
MVH reports grants from ZonMW Dutch Healthcare Fund, grants and personal fees from Pfizer-BMS, grants and personal fees from Bayer Health Care, grants and personal fees from Daiichi-Sankyo and grants from Leo Pharma, outside the submitted work.
ATAM has no disclosures.
LJM has no disclosures.
SM reports grants and personal fees from Daiichi Sankyo, grants and personal fees from Bayer, personal fees from BMS-Pfizer, personal fees from Boehringer-Ingelheim, personal fees from Portola and personal fees from Abbvie, outside the submitted work.
PP has no disclosures.
CJR has no disclosures.
AVN is supported by the Netherlands CardioVascular Research Initiative (CVON-2012–08 PHAEDRA, CVON-2017–10 DOLPHIN-GENESIS) and the Netherlands Organization for Scientific Research (NWO-VICI: 918.16.610). In addition, his institute received speaker’s money from Johnson & Johnson, MSD, Actelion, Bayer and Ferrer in the past 3 years. Finally, he served as a member of the scientific advisory board of Acceleron, MSD and Johnson & Johnson.
LJMK has no disclosures.
FAK reports research grants from Bayer, Bristol-Myers Squibb, Boehringer-Ingelheim, Daiichi-Sankyo, MSD and Actelion, the Dutch Heart Foundation (2017T064) and the Dutch Thrombosis association, all outside the submitted work.
Figures
Similar articles
-
Usefulness of standard computed tomography pulmonary angiography performed for acute pulmonary embolism for identification of chronic thromboembolic pulmonary hypertension: results of the InShape III study.J Heart Lung Transplant. 2019 Jul;38(7):731-738. doi: 10.1016/j.healun.2019.03.003. Epub 2019 Mar 15. J Heart Lung Transplant. 2019. PMID: 30962147
-
Identification of chronic thromboembolic pulmonary hypertension on CTPAs performed for diagnosing acute pulmonary embolism depending on level of expertise.Eur J Intern Med. 2021 Nov;93:64-70. doi: 10.1016/j.ejim.2021.07.001. Epub 2021 Jul 20. Eur J Intern Med. 2021. PMID: 34294517
-
Preexisting Chronic Thromboembolic Pulmonary Hypertension in Acute Pulmonary Embolism.Chest. 2023 Apr;163(4):923-932. doi: 10.1016/j.chest.2022.11.045. Epub 2023 Jan 5. Chest. 2023. PMID: 36621756
-
The diagnostic performance of CT pulmonary angiography in the detection of chronic thromboembolic pulmonary hypertension-systematic review and meta-analysis.Eur Radiol. 2022 Nov;32(11):7927-7935. doi: 10.1007/s00330-022-08804-5. Epub 2022 Apr 28. Eur Radiol. 2022. PMID: 35482124
-
A systematic literature review and meta-analysis of spectral CT compared to scintigraphy in the diagnosis of acute and chronic pulmonary embolisms.Eur Radiol. 2020 Jul;30(7):3624-3633. doi: 10.1007/s00330-020-06735-7. Epub 2020 Feb 28. Eur Radiol. 2020. PMID: 32112117
Cited by
-
Symptom-related screening programme for early detection of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the SYSPPE study.Thorax. 2024 Jan 18;79(2):144-152. doi: 10.1136/thorax-2023-220580. Thorax. 2024. PMID: 38050187 Free PMC article.
-
Investigation in image quality and immediate patient safety using pre-dual-flow injection for low-contrast dose spectral pulmonary artery CT angiography.Eur J Radiol Open. 2024 May 22;12:100571. doi: 10.1016/j.ejro.2024.100571. eCollection 2024 Jun. Eur J Radiol Open. 2024. PMID: 38859979 Free PMC article.
-
Even non-expert radiologists report chronic thromboembolic pulmonary hypertension (CTEPH) on CT pulmonary angiography with high sensitivity and almost perfect agreement.Eur Radiol. 2024 Feb;34(2):1086-1093. doi: 10.1007/s00330-023-10098-0. Epub 2023 Aug 22. Eur Radiol. 2024. PMID: 37606660
-
Pulmonary Embolism (PE) to Chronic Thromboembolic Pulmonary Disease (CTEPD): Findings from a Survey of UK Physicians.Adv Respir Med. 2024 Jan 9;92(1):45-57. doi: 10.3390/arm92010007. Adv Respir Med. 2024. PMID: 38247551 Free PMC article.
-
Pulmonary perfusion defects or residual vascular obstruction and persistent symptoms after pulmonary embolism: a systematic review and meta-analysis.ERJ Open Res. 2024 Jul 29;10(4):01010-2023. doi: 10.1183/23120541.01010-2023. eCollection 2024 Jul. ERJ Open Res. 2024. PMID: 39076522 Free PMC article.
References
-
- Klok FA, Barco S, Konstantinides SV et al (2018) Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry. Eur Respir J 52(6):1801687 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical